Key Points Deep clonal responses improve outcomes and can change the natural history of advanced (cardiac stage III) AL amyloidosis. NT-proBNP >8500 ng/L and SBP <100 mm Hg identify a very poor risk subgroup of stage III AL amyloidosis.
Support the authors with ResearchCoin
